Metabolic Disorder Clinical Trial
Official title:
A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan
Verified date | November 2012 |
Source | Asia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Taiwan: Department of Health |
Study type | Interventional |
The study was aimed to evaluate the effectiveness of a multidimensional worksite intervention program to reduce the severity of metabolic disorders in older workers in Taiwan.
Status | Completed |
Enrollment | 108 |
Est. completion date | December 2010 |
Est. primary completion date | October 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - full-time worker - aged 50 years or older - willing to complete a screening questionnaire - sign a study consent Exclusion Criteria: |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Asia University | Department of Health, Executive Yuan, R.O.C. (Taiwan) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in anthropometric and srum biochemical indicators. | Body weight (BW), body height, waist circumference, Body mass index (BMI), arterial blood pressure (BP), serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and glycosylated hemoglobin (HbA1c) concentrations | At baseline (week 0) and endpoint (week 24) of the intervention | No |
Secondary | Lifestyle factors | Physical activity, food consumption frequency and self-reported sleep and sedentary hours. | At baseline (week 0) and endpoint (week 24) of the intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00546052 -
A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)
|
Phase 3 | |
Completed |
NCT02650674 -
Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products
|
N/A | |
Completed |
NCT00707746 -
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
|
Phase 2 | |
Completed |
NCT02573103 -
Air Pollution and Cardiovascular Disease
|
||
Not yet recruiting |
NCT06051461 -
Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication
|
N/A | |
Not yet recruiting |
NCT05013112 -
Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)
|
N/A | |
Enrolling by invitation |
NCT04654000 -
Rheopheresis as Adjuvant Treatment of Calciphylaxis
|
N/A | |
Completed |
NCT01337141 -
A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients
|
N/A | |
Completed |
NCT00477594 -
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
|
Phase 2 | |
Recruiting |
NCT03882580 -
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
|
||
Active, not recruiting |
NCT01911091 -
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
|
N/A | |
Completed |
NCT00607373 -
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
|
Phase 3 | |
Completed |
NCT00362180 -
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
|
Phase 2 | |
Completed |
NCT03873948 -
Evaluation of Arginine in Periodontal and Cardiovascular Disease
|
||
Completed |
NCT02059993 -
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
|
N/A | |
Completed |
NCT06129578 -
Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals
|
N/A | |
Completed |
NCT06331572 -
Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
|
||
Completed |
NCT05255718 -
Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome
|
N/A | |
Completed |
NCT00694109 -
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
|
Phase 3 |